Accepted Presentations Showcase First-in-Human Development, Manufacturing Innovation, and Predictive Biomarkers for Deciparticleâ„¢ Everolimus (Sapu003) AGOURA HILLS, Calif., Oct. 23, 2025 (GLOBE ...